On 21 March, an advisory panel to the U.S. Food and Drug Administration gave its unanimous blessing to a piece of wearable technology that alleviates symptoms of the progressive eye disease glaucoma.
Known as the FSYX Ocular Pressure Adjusting Pump (OPAP) system, the device is designed to ease the pressure that accumulates in the eyes of people with glaucoma. This elevated pressure poses a risk of damaging the optic nerve, which relays visual information to the brain, leading to irreversible vision loss…
